High-Throughput Multiplexed Peptide-Centric Profiling Illustrates Both Substrate Cleavage Redundancy and Specificity in the MMP Family  by Kukreja, Muskan et al.
Resource
High-Throughput Multiplexed Peptide-Centric
Profiling Illustrates Both Substrate Cleavage
Redundancy and Specificity in the MMP FamilyGraphical AbstractHighlightsd Knowing the cleavage preferences is essential for
understanding the functions of MMPs
d Profiling of >18,500 peptide sequences determined the
cleavage preferences of 18 MMPs
d Our results enabled comparison of the cleavage preferences
of MMPs on a global scale
d This study generated a roadmap for the structural-functional
studies of MMPsKukreja et al., 2015, Chemistry & Biology 22, 1122–1133
August 20, 2015 ª2015 Elsevier Ltd All rights reserved
http://dx.doi.org/10.1016/j.chembiol.2015.07.008Authors
Muskan Kukreja, Sergey A. Shiryaev,
Piotr Cieplak, ..., Jeffrey W. Smith, Igor
A. Kozlov, Alex Y. Strongin
Correspondence
strongin@sanfordburnham.org
In Brief
Kukreja et al. present the results of the
high-throughput multiplexed profiling of
the cleavage preferences of 18
proteinases from the main sub-groups of
the MMP family that lead to defining the
substrate cleavage redundancy and
specificity in the MMP family, to a better
foundation for the follow-on structural-
functional studies of MMPs, and to a
means to predict in silico the cleavage
targets of the individual MMPs.
Chemistry & Biology
ResourceHigh-Throughput Multiplexed Peptide-Centric
Profiling Illustrates Both Substrate Cleavage
Redundancy and Specificity in the MMP Family
Muskan Kukreja,2,3 Sergey A. Shiryaev,1,3 Piotr Cieplak,1 Norihito Muranaka,2 David A. Routenberg,2 Andrei V. Chernov,1
Sonu Kumar,1 Albert G. Remacle,1 Jeffrey W. Smith,1 Igor A. Kozlov,2 and Alex Y. Strongin1,*
1Infectious and Inflammatory Disease Center/Cancer Research Center, Sanford-Burnham Medical Research Institute, 10901 North Torrey
Pines Road, La Jolla, CA 92037, USA
2Prognosys Biosciences Inc., San Diego, CA 92121, USA
3Co-first author
*Correspondence: strongin@sanfordburnham.org
http://dx.doi.org/10.1016/j.chembiol.2015.07.008SUMMARY
Matrix metalloproteinases (MMPs) play incompletely
understood roles in health and disease. Knowing the
MMP cleavage preferences is essential for a better
understanding of the MMP functions and design of
selective inhibitors. To elucidate the cleavage prefer-
ences of MMPs, we employed a high-throughput
multiplexed peptide-centric profiling technology
involving the cleavage of 18,583 peptides by 18
proteinases from the main sub-groups of the MMP
family. Our results enabled comparison of the MMP
substrates on a global scale, leading to the most effi-
cient and selective substrates. The data validated the
accuracy of our cleavage prediction software. This
software allows us and others to locate, with nearly
100% accuracy, the MMP cleavage sites in the
peptide sequences. In addition to increasing our
understanding of both the selectivity and the redun-
dancy of the MMP family, our study generated a
roadmap for the subsequent MMP structural-func-
tional studies and efficient substrate and inhibitor
design.
INTRODUCTION
Matrix metalloproteinases (MMPs) belong to a zinc endopepti-
dase, metzincin superfamily (Nagase and Fushimi, 2008; Nagase
et al., 2006), distinguished from other proteinases by the pres-
ence of a conserved HEXXHXXGXX(H/D) histidine sequence
motif. This motif displays three histidine residues that chelate
the active site zinc. The metzincin family is divided into four
sub-families: seralysins, astacins, adamalysins (ADAMs [pro-
teins with a disintegrin and a metalloproteinase domain] and
ADAM-TS [ADAM with thrombospondin-like motif]) and MMPs
(Gomis-Ruth, 2003, 2009).
There are 23 individual MMPs in humans, of which 17 protein-
ases are soluble and six aremembrane tethered (membrane type
[MT]-MMPs) (Puente et al., 2003). Normally, soluble MMPs are1122 Chemistry & Biology 22, 1122–1133, August 20, 2015 ª2015 Elsub-divided into four major sub-families such as collage-
nases (MMP-1/interstitial collagenase, MMP-8/collagenase-2,
and MMP-13/collagenase-3), stromelysins (MMP-3/stromely-
sin-1, MMP-10/stromelysin-2, and MMP-11/stromelysin-3),
gelatinases (MMP-2/gelatinase A and MMP-9/gelatinase B),
and matrilysins (MMP-7/matrilysin and MMP-26/matrilysin-2).
In addition, the MMP family includes several MMPs that
are not associated with these four sub-families such as MMP-
12/metalloelastase, MMP-19, MMP-20/enamelysin, MMP-21,
MMP-23, MMP-27, and MMP-28/epilysin. Among the six MT-
MMP sub-family members, four exhibit a transmembrane
domain and a short cytoplasmic tail (MMP-14/MT1-MMP,
MMP-15/MT2-MMP, MMP-16/MT3-MMP, and MMP-24/MT5-
MMP) and two attach to the cell membrane via a glycosylphos-
phatidyl inositol (GPI) anchor (MMP-17/MT4-MMP andMMP-25/
MT6-MMP) (Egeblad and Werb, 2002; Nagase and Woessner,
1999). With the exception of MMP-7 and MMP-26 that consist
of a catalytic domain alone, other MMPs have a C-terminal he-
mopexin-like domain linked to the catalytic domain by a flexible
hinge region.
MMPs are synthesized as latent zymogens. To become active
proteinases, the zymogens require proteolytic activation in
which the N-terminal inhibitory prodomain is removed and the
catalytic site of the emerging enzyme is exposed. Because of
their high degrading activity and potentially disastrous effect
on the microenvironment, cellular localization and activity of
MMPs are tightly controlled, either positively or negatively, at
both the transcriptional and post-transcriptional levels. In a feed-
back loop, some regulatory factors are either activated or inacti-
vated by MMP proteolysis (Kajita et al., 2001; McQuibban et al.,
2000; Mori et al., 2002; Rodriguez et al., 2010).
Evidence suggests that MMPs play an important role in extra-
cellular matrix proteolysis and tissue remodeling. In addition to
the matrix, MMPs cleave growth factors and cytokines, andmul-
tiple adhesion and signaling cell receptors (Belkin et al., 2001;
Dean et al., 2008; Deryugina et al., 2002; Mori et al., 2002).
Enhanced expression of MMPs often directly correlates with
malignant cell invasion and metastasis, and tumor neovasculari-
zation. Although our knowledge is expanding, we do not yet
understand the precise functional role of the individual MMPs
in normal compared with pathological conditions. Knockouts
of the individual MMP genes in mice, with the exception ofsevier Ltd All rights reserved
MMP-14, do not elicit an easily recognized phenotype and are
non-lethal, suggesting a functional redundancy among MMPs.
MMP-14 knockout, in turn, has a profound effect: MMP-14 null
mice develop dwarfism, and extensive bone malformations,
and die before adulthood (Holmbeck et al., 2004). Mice lacking
both MMP-2 and MMP-14 die immediately after birth (Oh
et al., 2004).
Despite multiple earlier studies, our abilities to quantitatively
estimate functional redundancy among MMPs and to rank pro-
tein substrates according to their sensitivity to MMPs were
limited. These deficiencies become especially important as
several MMPs, including MMP-8 and, potentially, MMP-19 and
MMP-25, demonstrate anti-tumor properties and thus should
not be pharmacologically targeted in certain malignancies while
the function of multiple additional MMPs remains unknown in the
context of disease (Chernov et al., 2010; Chernov and Strongin,
2011; Coussens et al., 2002; Gutierrez-Fernandez et al., 2008;
Overall and Kleifeld, 2006; Shay et al., 2015). Precise knowledge
of the MMP cleavage preferences is needed to rationally relate
MMPs to the cleaved substrates. Conversely, identification of
the multiple cleavage sequences is required to recognize the
cleavage signature of MMPs (Jabaiah and Daugherty, 2011).
This cleavage signature, if known, may directly relate the individ-
ual MMPs to their respective protein substrates (auf dem Keller
et al., 2010; Butler et al., 2008, 2009, 2010; Butler and Overall,
2007; Dean and Overall, 2007; Doucet et al., 2008, 2011; Dufour
and Overall, 2013; Overall and Kleifeld, 2006; Ratnikov et al.,
2014; Schlage and Auf dem Keller, 2015).
To determine cleavage preferences of MMPs, we employed a
high-throughput multiplexed peptide-centric profiling technol-
ogy developed by us (Kozlov et al., 2012; Shiryaev et al.,
2013a, 2013b, 2014). In this study, we treated a pool containing
18,583 peptide-cDNA fusions with 18MMPs (one proteinase per
reaction). As a result, we generated a volume of the peptide
cleavage data. These data enabled us to accomplish an in-depth
comparative analysis of substrate recognition by MMPs. There-
fore we were able, for the first time, to deliver comprehensive
information on both substrate cleavage redundancy and distinc-
tion in the MMP family.
RESULTS
Cleavage Profiling Technology
To characterize the cleavage preferences of the individual repre-
sentative proteinases of the human MMP family, we used a
high-throughput peptide-centric cleavage profiling technology.
This technology includes cleavage of a large number of pep-
tide-cDNA fusions designed in silico and then synthesized
in vitro. The technology has been tested and validated by deter-
mining cleavage preferences of several viral, bacterial, and
human proteinases (Kozlov et al., 2012; Shiryaev et al., 2012,
2013a, 2013b, 2014).
Here, we used the high-throughput multiplexed peptide-
centric profiling of the 18 individual MMPs. These MMPs repre-
sented the main sub-groups in the MMP family (collagenases,
gelatinases, stromelysins, and MT-MMPs). Each MMP was
allowed to cleave a library of 18,583 peptide-cDNA fusions.
The rules for designing 15,000 10-mer peptide sequences
were derived from our bioinformatics analysis of 1,369 peptideChemistry & Biology 22, 1122–sequences that were identified as the most efficient substrates
of MMPs in substrate phage display (Ratnikov et al., 2014).
This 15,000 peptide sub-set was generated by a random number
generator, resulting in a random combination of the accepted
residues at each of the individual P5-P50 positions, followed by
filtering out redundant sequences. Our set of 18,583 peptides
also included 598 sequences of the potential MMP cleavage
sites derived from the crystal structures of human secretory
proteins and, in addition, 2,985 control peptides, which included
the substrate peptides of non-MMP enzymes and random
sequences that were not cleaved by MMPs in our previous
experiments.
In our tests, aliquots of the peptide library were subjected
to cleavage by MMPs. The cDNA portions, which have been
released by MMP proteolysis of the peptide-cDNA fusions,
were collected. The nucleotide sequence of the released cDNA
templates was then determined using a high-throughput DNA
sequencer, thus providing the sequence of the encoded pep-
tides. The raw cleavage data of 18,583 individual peptides syn-
thesized, cleaved by the individual MMPs, and analyzed for
cleavage efficiency are presented in Table S1.
Cleavage Specificity of the MMP Catalytic Domain
versus the Full-Length MMP Enzyme
Because of its limited length, the 10-residue peptides can
occupy the MMP catalytic cleft, but they are not expected to
protrude outside the catalytic domain margins. To exclude any
significant, albeit unexpected, interactions of the peptide-DNA
fusions with the structural domains, which are distinct from
and additional to the MMP catalytic domain, the peptide-cDNA
fusion library was co-incubated with the individual catalytic
domains of MMP-2 and MMP-9, and with the full-length
MMP-2 and MMP-9 enzymes. Following MMP proteolysis of
the peptides and DNA sequencing of the samples, the individual
peptide-cDNA fusions with at least ten raw sequencing counts
(1,902 and 2,167 substrates for MMP-2 and MMP-9, respec-
tively) were analyzed further.
An average correlation coefficient among triplicate samples
was 0.92, suggesting a reliable execution of our cleavage as-
says. An average correlation coefficient between the full-length
MMP-2 and MMP-9 enzymes and the MMP-2 and MMP-9 cata-
lytic domains Z scores representing strength of the cleavagewas
0.72 and 0.77, respectively (Figure 1). These data suggested that
there was a high level of correlation between the cleavage pref-
erences of the catalytic domains and the full-length enzymes of
MMPs in our peptide cleavage assays. We concluded that the
use of the MMP catalytic domains provides reliable information
about the peptide cleavage preferences of MMPs and that the
effect of the MMP auxiliary domains is insignificant in our pep-
tide-centric assays.
MMP Profiling
Our cleavage analysis of the peptide-cDNA fusion library is
presented in Figure 2. The scatter density plots show the rela-
tions of the log-transformed raw sequencing counts versus the
Z scores of the individual peptide-cDNA fusions for the individual
MMPs. For each MMP, except for MMP-7 and MMP-19, we re-
corded >500 substrates with Z score >2.5, indicative of reliable
cleavage.1133, August 20, 2015 ª2015 Elsevier Ltd All rights reserved 1123
Figure 1. Cleavage Parameters of the
Catalytic Domains Versus the Full-Length
Enzymes of MMP-2 and MMP-9
The x axis and y axis denote the Z score of sub-
strate cleavage by the catalytic domain and by the
full-length proteinase, respectively. Black dots
represent selected substrates (1,902 for MMP-2
and 2,167 for MMP-9) with raw sequencing
counts >10. Red dotted line represents a linear
regression fitted line. Pearson’s correlation coef-
ficient and regression equation are shown within
the panels. Assays were performed in triplicate.
Average correlation among the replicates was
0.92 (not shown). Average correlation between the
full-length enzyme and the catalytic domain was
0.72 (MMP-2) and 0.77 (MMP-9).We then directly compared our kinetics data (in which the
cleavage readout was expressed as kcat/KM) (Ratnikov et al.,
2014) with our current data in a Z-score format. This comparison
allowed us to conclude that there was a direct correlation be-
tween both datasets. Thus, the kcat/KM value of 9,270 peptides
from the substrate phage display assays corresponded to the
Z score equal or above the value of 2.35 for the same peptides
in our current study. In general, these data indicated that from
the kinetics perspectives the selected range of the Z scores
corresponded to the efficient cleavage peptides. However, for
MMP-7 and MMP-19, in our peptide-centric assays we did
not observe significant substrates passing the threshold of
Z score >2.5. Hence, MMP-7 and MMP-19 were not analyzed
further.
The Pearson correlation coefficient matrix of the Z scores
(>0.7) of 18,583 peptide substrates showed a high correlation
among the members of the individual MMP sub-families (Fig-
ure 3). Thus, the specificity of MMP-14 highly correlated (an
average correlation coefficient over 0.8) with that of MMP-15,
MMP-16, and MMP-24, whereas no correlation was observed
with those of all soluble MMPs, in addition to MMP-17 and
MMP-25. Because the latter two are linked to the cell surface
via a GPI linker and, consequently, are in a distinct micro-
environment, it is not surprising that MMP-17 and MMP-25
exhibit distinct cleavage preferences relative to the four other
MT-MMPs.
Similarly, the cleavage preferences of MMP-1 correlated with
a correlation coefficient of 0.79 and 0.74 with those of MMP-8
and MMP-13, respectively, all three being members of the colla-
genase family. Conversely, the peptide cleavage pattern for the
members of the collagenase sub-family did not correlate well
with other MMPs except MMP-11. According to our data there
was a significant correlation (0.86) between the cleavage prefer-
ences of MMP-11 and the collagenase sub-family members
such as MMP-1 and MMP-8. These correlations indicate that
MMP-11 (stromelysin-3) shares substrate specificity with both
collagenase (MMP-1 and MMP-8) and the stromelysin (MMP-3
and MMP-10) sub-family members.
On the same note, from the cleavage perspectives MMP-12
resembled the members of the stromelysin sub-family, including
MMP-3 and MMP-10. There was also a level of correlation be-
tween MMP-12 and MMP-20, both of which correlated with1124 Chemistry & Biology 22, 1122–1133, August 20, 2015 ª2015 ElMMP-11, but not with other MMPs. In turn, MMP-12 shared
sequence preferences with none of the collagenase sub-family
members.
As expected the gelatinases, MMP-2 and MMP-9, exhibited a
significant similarity in their cleavage preferences (Bauvois,
2012). In addition, the cleavage preferences of MMP-2 were
similar with those of MMP-1, MMP-8, and MMP-13. This is not
entirely surprising because gelatinases efficiently degrade
gelatin (denatured collagen), and collagen is the main substrate
of the collagenase sub-family members.
In general, there was roughly a 50% overlap among the cleav-
age preferences of all MMPs, suggesting that approximately
50% of the peptide sequences that are cleaved by an individual
MMP would be also cleaved by all other MMPs. This high level
of cleavage preference redundancy explains the functional
redundancy observed among members of the MMP family. In
addition, this similarity of cleavage pattern among MMPs pro-
vides a fundamental rationale by which MMPs efficiently substi-
tute for one another in cells/tissues and, as a result, masking the
knockout phenotype in the MMP knockout mice.
Based on the Z-score parameter, we next selected the top 100
substrates for each MMP. These substrates were considered
to be the most efficiently cleaved substrate sequences. We
used this peptide sub-set to identify the preferred cleavage se-
quences for the individual MMPs. A direct relationship between
the peptide sequences and their susceptibility to MMP proteol-
ysis was visualized in a form of sequence logos. Since the design
of the peptide library was biased toward sequences containing
the motif PXX-L, the logos were normalized for the bias. For
eachMMP, themost frequent five-residue long P3-P20 sequence
motifs were selected (Figure 4). Clearly there is an overlap in the
cleavage preferences of MMPs. For example, a cleavage prefer-
ence overlap was evident for related MMP-1 and MMP-8 (colla-
genases-1 and -2, respectively). As a whole, all of the MMPs
were active against the peptides that exhibited the PXX-L cleav-
age motif at the P3-P10 positions.
There was also a level of distinction even between the most
closely related MMPs. To highlight this level of distinction and
to reveal the most selective, albeit not necessarily cleavage-effi-
cient, peptide sequences, each substrate for each MMP was
ranked based on the difference between the Z score for the
MMP of interest and the average Z score for all other MMPssevier Ltd All rights reserved
Figure 2. Scatter Density Plot for the 18 MMPs
Density plots of Z score versus raw sequencing counts of 18,583 peptide substrates. X axis and y axis denote the Z score of substrate cleavage and log2 rawDNA
counts in an MMP digest sample, respectively. Darker blue represents a higher density of substrates, with outlying substrates shown as dots (Z score >2.5;
p < 0.0062 by one-tailed test). All of the MMPs, except MMP-7 andMMP-19, exhibited >500 substrates with the Z score >2.5. Because of a limited number of the
efficiently cleaved peptide substrates, MMP-7 and MMP-19 were not analyzed further.for that particular substrate. An additional constraint was applied
to the Z score of the selected peptides for the MMP of interest
that it should exceed 1.65 (p value <0.05). As a result, we
selected the top 50 peptide substrates that were preferentially
specific and significantly proteolyzed by each MMP. For each
MMP, the most frequent five-residue long P3-P20 sequence
motifs were also selected (Figure 5).
To visualize both the similarity and difference in the cleavage
preferences among MMPs, we further used the top ten most
specific peptides (160 substrates for 16 MMPs) for the hierarchi-
cal clustering analysis based on Euclidian distance and average
linkage algorithm, and represented as a heatmap (Figure 6; red,
black, and blue designate the high, medium, and low Z scores,
respectively). The distinct diagonal pattern of the efficientlyChemistry & Biology 22, 1122–cleaved peptides (red) highlights the substrates that were most
specifically cleaved by a particular MMP but were inefficiently
cleaved by other MMPs.
Correlation with PWM Predictions
Recently, based on the substrate phage display data (Ratnikov
et al., 2014), we developed the positional weight matrix (PWM)
prediction methodology (http://cleavpredict.sanfordburnham.
org). PWM was designed to predict the MMP cleavage sites in
the peptide/protein sequences (Kumar et al., 2015). To test the
accuracy of our PWM software in relation to the current cleavage
data, we analyzed all substrates with Z score >2.5 for 11
MMPs (MMP-2, -3, -8, -9, -10, -14, -15, -16, -17, -24, and -25).
The level of correlation between the PWM predictions and the1133, August 20, 2015 ª2015 Elsevier Ltd All rights reserved 1125
Figure 3. Pearson’s Correlation Coefficient Matrix of the Z Scores of 18,583 Peptide Substrates Cleaved by MMPs
The bottom triangular matrix shows raw correlation coefficient. The top triangular matrix represents a degree of correlation in the form of an ellipse (a low minor
axis denotes a high correlation). To aid the eye, the color of the coefficient and ellipse also indicates the correlation strength. Cyan indicates low correlation
(0–0.3), blue denotes medium correlation (0.3–0.8), and red denotes high correlation (0.8–1) among the MMP cleavage preferences.experimental Z scores was generally very high. Nearly all of the
substrates that were efficiently cleaved were predicted to be
efficiently cleaved by PWM (92%–99.7%) (Table 1; Figure S1).
A significant level of correlation of the experimental results pub-
lished by others (Turk et al., 2001) with the predicted PWM
scores serves as additional validation of our CleavPredict soft-
ware (Table S2). Furthermore, multiple protein targets of MMP-
2 and MMP-9 identified by others (Prudova et al., 2010; Schilling
and Overall, 2007, 2008) were readily identified by CleavPredict,
both with high accuracy and precision (discussed in Kumar et al.,
2015).
DISCUSSION
The capability of proteinases to catalytically cleave substrate
proteins post-synthesis is essential for sustaining life in all of
its forms, from viruses to humans. It is widely accepted that
limited, site-specific proteolysis is one of the most important1126 Chemistry & Biology 22, 1122–1133, August 20, 2015 ª2015 Elpost-translational modifications, especially because this post-
translational modification, in contrast to others, is irreversible
under physiological conditions.
Understanding of the physiological role of a protease requires
identification of both its cleavage substrates and its cleavage
efficacy against the substrate(s) relative to others. Knowing
these cleavage specificity and efficiency parameters can greatly
improve our ability to rationally use proteinases in health
research, medicine, and biotechnology. In addition, this knowl-
edge, once acquired experimentally and then transformed
into user-friendly software, will be highly valuable for laboratory
researchers.
As a step toward these goals, we used an unbiased
approach to identify the relative primary cleavage specificity
and efficiency parameters for an important group of human
proteinases, the MMP family. MMPs play multiple diverse
roles in both normal development and pathologies, especially
malignancy and metastasis. MMPs exhibit similar catalyticsevier Ltd All rights reserved
Figure 4. Frequency Plot of the Efficient Cleavage Sequences of MMPs in an IceLogo Format
The height of a character is proportional to the frequency of the amino acid residue at the individual position of the cleaved peptide. 18,583 peptide substrates
were cleaved by the individual MMPs. The scissile bond is between the P1 and P10 residues. The Z scores for the substrates were calculated and the substrates
ranked according to their Z scores. The most efficient 100 substrates (Z score >2; p < 0.02) were selected for each MMP. Because the design of the peptide
substrates was biased to the PXXL-containing sequences, the resulting position-specific matrix of the top 100 substrates was normalized at each position by
using the amino acid residue frequency at this particular position in the entire 18,583 peptide library. The five most frequently occurring sequence motifs for each
MMP are also shown.domain folds and highly homologous active site structures.
These parameters contribute to the functional redundancy
in the MMP family and cause difficulty in designing selective
MMP inhibitors (Maskos, 2005; Zucker et al., 2000). Compre-
hensive assessment of these cleavage parameters requires
the availability of volumes of the cleavage data, but so farChemistry & Biology 22, 1122–these data have been quite limited (Kazanov et al., 2011; Rat-
nikov et al., 2014).
Here, we employed high-throughput multiplexed peptide-
centricprofiling formultipleMMPs.TheMMPspeciesweanalyzed
included the members of the representative MMP sub-families
(collagenases, gelatinases, stromelysins, and MT-MMPs). As a1133, August 20, 2015 ª2015 Elsevier Ltd All rights reserved 1127
Figure 5. Frequency Plot of the Selective Cleavage Sequences of MMPs in an IceLogo Format
The height of a character is proportional to the frequency of the amino acid residue at the individual position of the cleaved peptide. Substrates were ranked
according to the difference between their Z score for the particular MMP and Z score for all of other MMPs. The top 50 peptide substrates were selected for each
MMP (Z score >1.65; p < 0.05). Because the design of the peptide substrates was biased to the PXXL-containing sequences, the resulting position-specificmatrix
of the top 50 substrates was normalized at each position by using the amino acid residue frequency at this particular position in the entire 18,583 peptide library.
The three most frequent sequence motifs for each MMP are also shown.result,wecannowconfidently conclude that that there is a roughly
50% overlap in the cleavage preferences on MMPs. This means
that if a peptide substrate is cleaved by a single MMP there is a
50% probability that this particular peptide sequence will be
cleaved by many others, if not all, MMPs.
In addition, our data highlighted the subtle differences in the
cleavage preferences among MMPs and allowed us to deter-1128 Chemistry & Biology 22, 1122–1133, August 20, 2015 ª2015 Elmine the most efficient substrates and, conversely, the most se-
lective peptide cleavage sequences for the individual, even
closely related, MMPs. Thus, for example, the presence of
Asp at the P10 position would allow the discrimination of
MMP-8 (collagenase-2) not only from the closely related
MMP-1 (interstitial collagenase) but also from all other MMPs.
Furthermore, in addition to the well-established structuralsevier Ltd All rights reserved
Figure 6. Supervised Clustering of the Ten Most Selective Peptide Substrates for Each of the MMPs in a Heatmap Format
Z scores indicating cleavage activity of all 18,583 peptide substrates were calculated for each MMP, and all substrates were ranked according to their Z score
difference relative to all other MMPs. The top ten most selective substrates were chosen for each MMP (Z score >1.65). X axis shows MMPs; y axis shows 160
peptides (top ten specific peptides for each MMP). Red, black, and blue designate high, medium, and low Z scores, respectively.homology parameters, we now can exploit the cleavage prefer-
ences perspective to additionally define the relations existing
among the MMP sub-families and the individual proteinases.
Thus, as judged from their sequence preferences, MMP-11
(stromelysin-3) is likely closely related to both the collagenase
and stromelysin sub-families. In agreement, evolutionary path-
ways suggest that MMP-11 co-evolved closely with the MT-
MMP sub-family and that the other two stromelysins (MMP-3
and MMP-10) strongly diverge from MMP-11. In turn, based
on both the MMP cleavage preferences we recorded and the
position of MMP-12 in the evolutionary tree (Fu et al., 2009;
Massova et al., 1998), MMP-12 also appears to be close to
the stromelysins. Our data summarized in Figure 6 allow usChemistry & Biology 22, 1122–and others to select the peptide sequences that are most biased
to the individual MMPs and, at the same time, forecast the inter-
ference of other individual MMP type in the cleavage of this in-
dividual peptide. Because of our unbiased approach, our results
will facilitate the exploration of many novel biological roles for
multiple individual MMPs, a significant challenge for current
modalities.
Furthermore, our cleavage data could be further exploited by
bioinformatics researchers in an attempt to identify those varia-
tions in the MMP sequence and structure that result in the
distinct cleavage preferences among the MMP family members.
Consequently, knowing these specificity-determining residues
may ultimately lead to the design of mutant MMPs biased to1133, August 20, 2015 ª2015 Elsevier Ltd All rights reserved 1129
Table 1. Peptide Substrates with the Z score >2.5 for Each MMP
MMP
No. of
Substrates with
Z Score >2.5
No. (%) of
Substrates
Predicted
by PWM
No. (%) of
Substrates
Not Predicted
by PWM
MMP-2 499 457 (92%) 42 (8%)
MMP-3 198 184 (93%) 14 (7%)
MMP-8 418 415 (99.3%) 3 (0.7%)
MMP-9 178 174 (97.8%) 4 (2.2%)
MMP-10 334 310 (93%) 24 (7%)
MMP-14 568 566 (99.7%) 2 (0.3%)
MMP-15 164 163 (99.4%) 1 (0.6%)
MMP-16 311 310 (99.7%) 1 (0.3%)
MMP-17 177 175 (98.9%) 2 (1.1%)
MMP-24 367 354 (96.5%) 13 (3.5%)
MMP-25 402 400 (99.5%) 2 (0.5%)
Substrates with the Z score >2.5 that are not predicted by the PWM soft-
ware are shown as red dots in Figure S1.the efficient proteolysis of the particular clinically or bio-
technologically relevant protein targets.
Volumes of the cleavage data we generated also allowed us to
critically assess the cleavage prediction PWM algorithm we de-
signed based on the less voluminous data (Kumar et al., 2015;
Ratnikov et al., 2014). According to our analysis, under exhaus-
tive proteolysis conditions PWM correctly predicts, on average,
more than 93% of the cleavage sites in peptides, reaching a
nearly 100% accuracy level for certain MMPs (Table 1). This
high level of correlation implies that the open-access PWM
software (http://cleavpredict.sanfordburnham.org) exhibited a
significant predictive power and that this software can be recom-
mended for the use by others. We admit, however, that descrip-
tors deduced directly from the amino acid sequence exhibit
incomplete predictive capabilities. Because of the effect of the
MMP auxiliary domains, structural constraints, and spatial-
temporal differences between the substrate and the protease,
peptide cleavage in in vitro assays may not always predict that
the same sequence is targeted in a natural protein. These limita-
tions are discussed in a detail in our other publications (Belushkin
et al., 2014; Kazanov et al., 2011; Kumar et al., 2015).
Overall, in addition to increasing our fundamental understand-
ing of MMP proteolysis, our results provide a roadmap for the
design of both the most efficient and, alternatively, most selec-
tive cleavage substrates for the individual MMPs. These sub-
strates can be used in various applications including the design
of quenched peptides, biosensors, drug delivery reagents, and
many other molecular tools whereby MMP proteolysis is
required for the emerging biological effect (Lu et al., 2013;
Ouyang et al., 2010). We believe that our results will stimulate
and focus functional studies by others in both biology and med-
icine. Thus, evidence suggests that: (1) enhanced activities of
MMPs are important to multiple pathologies; (2) measuring just
one individual protease is unlikely to be representative of the pro-
teolytic environment; (3) no diagnostic/theranostic tests are
currently available to detect elevation in MMP activity levels;
and (4) the development of diagnostic tests based on the MMP
activities could dramatically change the provision of care, espe-1130 Chemistry & Biology 22, 1122–1133, August 20, 2015 ª2015 Elcially in outpatient settings. Ultimately, our work will bring us a
step closer to proteolysis-targeting personalized medicine.
SIGNIFICANCE
Proteolysis is of paramount importance to biological regula-
tion and life in all of its forms, in both normal development
and disease. The significance of proteolysis is magnified
because, in contrast to other post-translational modifica-
tions, proteolysis is irreversible under physiological condi-
tions. Our study is a step forward toward determining the
cleavage preferences of proteinases and then computation-
ally connecting the proteinases with their previously un-
known substrates in the proteome. Here, our focus is on
the MMP family. Thus, we used an unbiased approach to
identify the relative cleavage specificity and efficiency
parameters for the members of the representative MMP
sub-families (collagenases, gelatinases, stromelysins, and
MT-MMPs). For these purposes, we employed a high-
throughputmultiplexed peptide-centric profiling technology
that we have recently developed and employed successfully
to determine the cleavage preferences of several bacterial,
viral, and human proteinases. In our current study, we
treated a pool containing 18,583 peptide-cDNA fusions
with 18 MMPs. As a result, we generated a volume of the
peptide cleavage data. These data enabled us to accomplish
a comparative analysis of substrate recognition by MMPs
and to deliver comprehensive information on both substrate
cleavage redundancy and distinction for the individualmem-
bers of the MMP family. Based on our data, the more selec-
tive and efficient substrates and inhibitors of MMP can be
designed. Volumes of the cleavage data we generated also
allowed us to critically assess the cleavage prediction
PWM algorithm we have developed. Following our compre-
hensive tests, we are now confident that the open-access
PWMsoftware (http://cleavpredict.sanfordburnham.org) ex-
hibits a significant predictive power and that this software
can be recommended for use by others who are trying to
connect the MMP family members with their novel respec-
tive substrates.
EXPERIMENTAL PROCEDURES
General Reagents
The reagents were purchased from Sigma-Aldrich unless indicated otherwise.
The broad-spectrum Mca-Pro-Leu-Gly-Leu-Dpa-Ala-Arg-NH2 substrate was
acquired from R&D Systems. The catalytic domains of MMP-1, -2, -3, -7, -9,
-10, -11, -12, -13, -19, and -20 were from Enzo Life Sciences. The catalytic do-
mains of MMP-8, -14, -15, -16, -24, and -25 were isolated in our laboratories
(Shiryaev et al., 2009a, 2009b). The full-length MMP-2 and MMP-9 were iso-
lated and then activated by p-aminophenylmercuric acetate (Chen et al.,
2002).
MMP Activity Assay with the Quenched Peptide Substrate
To standardize the activity for each MMP, a cleavage activity assay was per-
formed in triplicate in wells of a 96-well plate (0.2-ml reaction volume) in 50mM
HEPES buffer (pH 6.8) containing 10 mM CaCl2 and 50 mM ZnCl2. The Mca-
Pro-Leu-Gly-Leu-Dpa-Ala-Arg-NH2 substrate and enzyme concentrations
were 10 mM and 10 nM, respectively. Initial reaction velocities were monitored
continuously at lex = 320 nm and lem = 400 nm on a fluorescence spectropho-
tometer. The determined activity and amounts of each MMP were thensevier Ltd All rights reserved
normalized relative to the activity and amounts of the standard full-length
MMP-2 enzyme solution of a known concentration. As a result of both of these
activity measurements and our preliminary tests and assays, a 2-nM equiva-
lent of MMP-2 was used for each individual MMP in the multiplex peptide
cleavage assays described below.
The Substrate Library
To elucidate the MMP cleavage preferences, we prepared a set of 18,583
peptide-cDNA fusions. Each fusion construct contained a ten-residue peptide
substrate flanked by N- and C-terminal common sequences. Statements
below regarding peptides refer only to the variable 10-mer portions of the pep-
tides and disregard the flanking constant portions. The 18,583 set included
several sub-sets. The main sub-set we designed in silico included approxi-
mately 15,000 peptide sequences that we expected to be cleaved efficiently
by MMPs. The design rules were derived from our bioinformatics analysis of
1,369 peptide sequences that were identified as the most efficient substrates
of MMPs using phage display methods (Ratnikov et al., 2009, 2014). We used
these validated substrate sequences to identify amino acid residue types that
are accepted byMMP-2, -9, -14, -15, -16, -24, and -25 at each of the individual
P5-P50 substrate positions. We then used a random number generator to
create multiple peptide sequences. For this purpose, we used a random com-
bination of those residues accepted by MMPs and identified in our earlier
studies at each of the individual P5-P50 positions (Ratnikov et al., 2014). Dupli-
cate sequences, if they were present, were then filtered out. We also excluded
peptides that were predicted to be inefficient MMP substrates based on
the statistical substrate specificity profiling software predictions (http://
cleavpredict.sanfordburnham.org) (Kumar et al., 2015).
Based on the specificity profiling software predictions and the crystal struc-
tures of secretory proteins available from the PDB database, we included 598
additional peptide sequences that were likely MMP cleavage substrates. The
set of 18,583 peptides also included 1,643 control peptides containing the
furin cleavage motif. Additional positive and negative controls included known
peptide substrates of thrombin, enterokinase, caspases, and West Nile and
Dengue virus proteinases, and randomly generated sequences.
Multiplex Peptide Cleavage Assay and Data Analysis
Biotinylated peptide-cDNA pool was prepared as reported earlier (Kozlov
et al., 2012). The template DNAs encoded 18,583 10-mer peptide substrates
flanked by the N-terminal (Biotin-linker-Gly-Ala) and C-terminal (Gly-Asn-
Ala-Ser-Ala-Ser-Ala-Ala-Gly-Ala-linker-DNA) common sequences. Six bio-
tinylated oligonucleotides of a known concentration were added to the
peptide-cDNA pool as internal standards for normalization. Streptavidin-
coated magnetic beads with the immobilized peptide-cDNA pool (1 pmol
total,0.05 fmol/peptide) were co-incubated with the individual MMPs in trip-
licate (2 nMMMP-2 equivalent each) at 37C for 30min (3 ml reaction volume) in
50 mM HEPES (pH 6.8), containing 10 mM CaCl2 and 50 mM ZnCl2. Reactions
without proteinases were used as controls. Following cleavage of the peptide-
cDNA fusions by MMPs, the cleaved peptide-cDNA fragments were released
from the beads and solubilized in the reaction solution. The reaction solutions
were separated from the beads and collected. To identify cleaved peptides,
DNA adapters required for sequencing were installed in the released cDNA
by PCR. The obtained DNA constructs were sequenced using an MiSeq
sequencing instrument (Illumina).
Total sequencing counts for each sample were normalized using the added
internal standards. Abundance of each cleaved, solubilized peptide was quan-
tified by counting the number of DNA reads corresponding to the peptide
sequence, resulting in the discrete count data of 18,583 peptide substrates
for each of the 18 MMPs studied. The cleavage level (Z score) for each sub-
strate in a sample was then calculated as a function of the average counts
of the three replicates in the proteinase-treated samples and the average
counts in the control samples (no MMP, buffer only) as described below.
The cleavage level was estimated by comparing the log-transformed counts
in the MMP-treated versus the control samples. To adjust for sequence-spe-
cific variance in the abundance levels of each peptide present in the pool, we
used a locally weighted scatterplot smoothing fit as implemented in the lowess
(locally weighted scatterplot smoothing) function from the statistical analysis
package R. Our past data indicated that variance in our data was not constant
but was rather a function of abundance; this is the primary reason for choosingChemistry & Biology 22, 1122–the lowess function rather than traditional linear regression. The residual of the
lowess fit for each peptide, i.e., the deviation from the lowess line, was ob-
tained with positive residuals (peptide abundances, which are above the
line), indicating a higher relative abundance in protease compared with buffer
and negative residuals indicating a lower relative abundance. Each residual
was then standardized and transformed into a Z score by subtracting the
mean of all residues and dividing by the SD of all residuals: Z score =
[residuals(i) mean (all residuals)]/SD (all residuals). After this transformation,
Z scores of the intact peptides were shown to have a standard normal
distribution (mean = 0 and SD = 1). Statistical significance was inferred by con-
verting Z scores into p values by 1  pnorm (Z value) in R. A higher Z score in-
dicates a higher cleavage activity and a lower p value of a peptide substrate.
We chose a significance cut-off for each peptide of p value <0.05 after adjust-
ing for multiple testing corrections according to the method of Benjamini and
Hochberg (1995). Substrates with cleavage efficiency below the threshold
(Z score <1.65, which corresponded to a p value of 0.05) were considered
resistant to MMP proteolysis.
The sequence logos for the selected MMP substrate peptides were created
using the Web-based IceLogo program (Colaert et al., 2009). The listing of the
most sensitive 100 peptides was compiled by taking 100 peptides for each
MMP with the highest Z scores (all values passed the significance cut-off of
p < 0.02 and Z score >2). The listing of the most selective 50 substrates for
each MMP was compiled by ranking substrates whose Z score was higher
than the average of all other MMPs for this particular substrate peptide (these
top 50 peptides had Z score >1.65 and p < 0.05), indicating that this peptide
was preferred by a particular MMP and was not preferred by any other MMP.PWM and Substrate Cleavage Predictions for Individual MMPs
We used the PWMapproach for calculating the cleavage score of the peptides
(Kumar et al., 2015). The previous cleavage data from the substrate phage
display (Ratnikov et al., 2014) were used to design peptide substrates for
the 11 individual MMPs (MMP-2, -3, -8, -9, -10, -14, -15, -16, -17, -24,
and -25). The PWM values were calculated for each MMP by (1) aligning the
peptide sequence with that of the potential cleavage site, (2) calculating the
frequencies (P(iAA,j)) of occurrence of each amino acid type (iAA) in each of
the jth positions, ranging from P3 to P20, and (3) normalizing each amino acid
residue position relative to the distribution of amino acid residue types in the
set of the background sequences. The background sequences were obtained
from 766 peptides for which cleavage frequency was below 10% in our sub-
strate phage display studies (Ratnikov et al., 2014). Thus, the final PWM values
for each amino acid iAA at the j
th position were calculated as:
PWMðiAA; jÞ= PðiAA; jÞ
PbckgrðiAA; jÞ : (Equation 1)
We used the log2 values of the appropriate PWM elements as the primary
scoring function for substrate prediction. The actual cleavage recognition
score is defined in Equations 2 and 3 as a sum of log2 of PWMmatrix elements
for iAA amino acid type at the j
th position. Summation runs over the P3-P20 po-
sitions in the substrate:
Score=
XP20
j =P3
SjðiAAÞ; (Equation 2)
where SjðiAAÞ=
8><
>:
log2

PðiAA; jÞ
PbckgrðiAA; jÞ

offset; if PðiAA; jÞ= 0
: (Equation 3)
If any element of the PWM was equal to zero, the offset value was used
instead. This was done to avoid calculation of log2(0) and yet to add sufficient
penalty to the scoring function if an amino acid type iAA at j
th position was not
observed in the training set. If the PWM score was above the cut-off value, the
peptide bond was considered as a potential cleavage site. Both offset and cut-
off values were specific for each MMP and optimized by using a two-
dimensional 10-fold cross-validation in which the F1 score was maximized.
This primary scoring function was used to screen every peptide bond in the
peptide sequences and to predict whether the peptide may be cleaved by
the individual MMP.1133, August 20, 2015 ª2015 Elsevier Ltd All rights reserved 1131
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